Meeder Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,895
| Closed | -$16K | – | 2603 |
|
|
2020
Q1 | $16K | Buy |
1,895
+1,034
| +120% | +$8.73K | ﹤0.01% | 1340 |
|
|
2019
Q4 | $8K | Sell |
861
-451
| -34% | -$4.19K | ﹤0.01% | 1657 |
|
|
2019
Q3 | $8K | Buy |
1,312
+1,013
| +339% | +$6.18K | ﹤0.01% | 1620 |
|
|
2019
Q2 | $4K | Buy |
+299
| New | +$4K | ﹤0.01% | 1759 |
|
|
2019
Q1 | – | Sell |
-137
| Closed | -$2K | – | 1919 |
|
|
2018
Q4 | $2K | Buy |
137
+109
| +389% | +$1.59K | ﹤0.01% | 1594 |
|
|
2018
Q3 | $0 | Sell |
28
-6,277
| -100% | – | ﹤0.01% | 1733 |
|
|
2018
Q2 | $106K | Buy |
6,305
+5,496
| +679% | +$92.5K | 0.01% | 619 |
|
|
2018
Q1 | $19K | Buy |
809
+593
| +275% | +$13.9K | ﹤0.01% | 906 |
|
|
2017
Q4 | $5K | Sell |
216
-12
| -5% | -$278 | ﹤0.01% | 1333 |
|
|
2017
Q3 | $3K | Sell |
228
-129
| -36% | -$1.7K | ﹤0.01% | 1405 |
|
|
2017
Q2 | $5K | Buy |
357
+60
| +20% | +$840 | ﹤0.01% | 1218 |
|
|
2017
Q1 | $5K | Sell |
297
-1,205
| -80% | -$20.3K | ﹤0.01% | 1111 |
|
|
2016
Q4 | $15K | Buy |
+1,502
| New | +$15K | ﹤0.01% | 695 |
|